GSK - VIIV HEALTHCARE AND SHIONOGI INTEND TO INITIATE FIRST TIME IN HUMAN STUDIES WITH S-365598 BY 2023.
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Gsk - Viiv Healthcare And Shionogi Intend To Initiate First Time In Human Studies With S-365598 By 2023.